Fda guidance for pharmaceutical post marketing reporting professor pirouzi
ICH - E2D Pharmacovigilance and Drug Safety - Professor Peivand Pirouzi
ICH E14 on LQTc syndrome for non-antiarrythmic drugs - Professor Peivand Pirouzi
Health Canada guidance for biotechnology products - Professor Peivand Pirouzi
FDA Guidance for risk evaluation and mitigation strategies - Professor Peivand Pirouzi
Clinical Research Challenges and Best Practices in Pediatric Research in Canada - Dr. Al Wahab - 2015
Parkinson’s disease clinical research challenges and best practices 2015
Pharmaceutical Global Regulatory Affairs: Spain - by Aalmudena Camacho 2015
Pharmaceutical Regulatory Affairs in Australia - by Youssef El-Nazer & Hamid Zareian 2015
Approach to Therapeutic Recreation Based Clinical Research Outcome Measures
Writing a Study Protocol for Therapeutic Recreation Studies in Canada
Therapeutic Recreation Fieldwork Placement System
Protection of Human Subjects in Therapeutic Recreation Research in Canada
Pr. Peivand Pirouzi - Lung or Lung and Heart Transplants - Clinical trial protocol writing and study presentation
Pr. Peivand Pirouzi - Dr. Hamid Reza Bokaee Research Project Presentation 2015
Pr. Peivand Pirouzi - Use of inhaled long acting beta2 adrenoceptor agonists and acute myocardial infarction 2014
Pr. Peivand Pirouzi - Calcium channel blocker treatments and cancer risk 2015 - Students Research Project Introduction at AAPS
Professor Peivand Pirouzi - International clinical study and safety reporting activities - Publication, Canada - All rights reserved
Pharmaceutical Global Regulatory Affairs: Japan - by Jieun Lim and Mozhdeh Alemi
Pharmaceutical Biotechnology Research Presentation : Recombinant Streptokinase